ENANTA PHARMACEUTICALS, INC
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $35.8M | $31.1M | $4.7M | $9.4M |
| FY2017 | $52.7M | $50.1M | $2.5M | $13.1M |
| FY2018 | $29.2M | $26.2M | $3.0M | $15.8M |
| FY2019 | $71.4M | $66.0M | $5.4M | $19.2M |
| FY2020 | $7.1M | $5.6M | $1.4M | $19.6M |
| FY2021 | $-70.0M | $-70.7M | $750.0K | $21.0M |
| FY2022 | $-84.8M | $-86.9M | $2.1M | $27.0M |
| FY2023 | $-103.2M | $-112.2M | $9.1M | $28.2M |
| FY2024 | $-78.8M | $-96.7M | $17.9M | $26.8M |
| FY2025 | $-19.3M | $-32.2M | $12.9M | $18.6M |